The calcineurin signaling pathway is a critical mediator of pressure overload-induced cardiac hypertrophy, representing a potential therapeutic target.
The present results suggest that the calcineurin signaling pathway plays a pivotal role in load-induced cardiac hypertrophy and may pave the way for a novel pharmacological approach to prevent cardiac hypertrophy.
Shimoyama et al. (Tue,) studied this question.